Table 1.
Cytokine | Reported outcome in VVC/RVVC |
References | |||
---|---|---|---|---|---|
Humans | Mice | Rats | |||
Th1 | IL-2 | P− | P+ | P+ | [37, 43, 44, 52, 114] |
IL-12 | P− | P− | P+ | [34, 37, 52, 114] | |
IFN-γ | P−, S+ | P− | P+ | [34, 37, 51, 52] | |
Th2 | IL-4 | P−, S+ | S+ | P− | [34, 37, 42, 43, 51, 115] |
IL-5 | P− | P− | [37, 115] | ||
IL-13 | S+ | [115] | |||
Th17 | IL-23 | P− | P− | [14, 58](Fidel, submitted) | |
IL-17 | P+/− | P+/− | [13, 58](Fidel, submitted) | ||
IL-22 | P− | (Fidel, submitted) | |||
Proinflammatory | IL-1α | P− | [34] | ||
IL-6 | P− | P+ | [13, 34, 44, 114] | ||
G-CSF | P− | P− | [13](Fidel, unpublished data) | ||
TNF-α | P− | P+ | [34, 114] | ||
Regulatory | TGF-β | I+ | I+ | [29, 34, 35, 43] | |
IL-10 | P− | P−, S+ | P+ | [29, 34, 43, 44, 114] | |
Chemokines | MCP-1 | P− | [29, 30] | ||
RANTES | P− | [30] | |||
IL-8/MIP-2 | P−, S+ | P− | [30, 51, 71] | ||
MIP-1α | P− | [30] |
P, protection; S, susceptibility; I, immunoregulation; +, reported role; −, reported lack of a role